The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study
Abstract
Introduction: Autoimmunity against the TSH receptor is a key pathogenic element in Graves' disease. The autoimmune aberration may be modified by therapy of the hyperthyroidism. Objective: To compare the effects of the common types of therapy for Graves' hyperthyroidism on TSH-receptor autoimmunity. Methods: Patients with newly diagnosed Graves' hyperthyroidism aged 20–55 years were randomized to medical therapy, thyroid surgery, or radioiodine therapy (radioiodine was only given to patients ≥35 years of age). l -thyroxine ( l -T 4 ) was added to therapy as appropriate to keep patients euthyroid. Anti-thyroid drugs were withdrawn after 18 months of therapy. TSH-receptor antibodies (TRAb) in serum were measured before and for 5 years after the initiation of therapy. Results: Medical therapy ( n =48) and surgery ( n =47) were followed by a gradual decrease in TRAb in serum, with the disappearance of TRAb in 70–80% of the patients after 18 months. Radioiodine therapy ( n =36) led to a 1-year long worsening of autoimmunity against the TSH receptor, and the number of patients entering remission of TSH-receptor autoimmunity with the disappearance of TRAb from serum during the following years was considerably lower than with the other types of therapy. Conclusion: The majority of patients with Graves' disease gradually enter remission of TSH-receptor autoimmunity during medical or after surgical therapy, with no difference between the types of therapy. Remission of TSH-receptor autoimmunity after radioiodine therapy is less common.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the group with elevated TRAb, relapse rates approach 80%-100%, while in the latter group, relapse rates are in the 20%-30% range (171,172).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [172]
In the citing paper
“TRAb assessment at the end of the course of ATD therapy is a useful method of dividing patients into two groups: one with persistent elevations who are unlikely to be in remission, and another group with low or undetectable TRAb, who have a higher probability of permanent remission (171,172).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [172]
In the citing paper
“Whereas monitoring of TRAb levels while on ATDs has been shown to be useful in adult patients for predicting the likelihood of remission or relapse of GD after stopping the medication (172), this approach has yet to be validated in children.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [172]
In the citing paper
“The higher risk of GO development after RAI therapy in the majority of studies may be related to the unique increase in TRAb levels observed following this therapy (172).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [172]
Citations
Cites
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Self-citationEpidemiology and Prevention of Graves' Ophthalmopathy
Wiersinga, W. M., & Bartalena, L. (2002) · Thyroid · doi:10.1089/105072502761016476 · Cited by 457
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
Gerding, M. N., Meer, J. W. C. V. D., Broenink, M., Bakker, O., Wiersinga, W. M., & Prummel, M. F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00959.x · Cited by 328
Törring, O., Tallstedt, L., Wallin, G., Lundell, G. E. F., Ljunggren, J. ‐., Taube, A., Sääf, M., & Hamberger, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768863 · Cited by 311
Self-citationCarbimazole and the Autoimmune Response in Graves' Disease
McGregor, A. M., Petersen, M. M., McLachlan, S. M., Rooke, P., Smith, B. R., & Hall, R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008073030603 · Cited by 274
Thyrotropin receptor-associated diseases: from adenomata to Graves disease
Davies, T. F. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26031 · Cited by 260
Fatourechi, V. (2005) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200506050-00003 · Cited by 207
LIPPE, B. M., LANDAW, E. M., & KAPLAN, S. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1241 · Cited by 192
Laurberg, P., Nygaard, B., Glinoer, D., Grussendorf, M., & Orgiazzi, J. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390584 · Cited by 191
Self-citation
Flagged first, then by citations
Research works printed but not linked: 8
- 1992, New England Journal of Medicine, 25, 1733
- Torring, 1996, Journal of Clinical Endocrinology & Metabolism, 81, 2986, 10.1210/jc.81.8.2986 · DOI
- Smith, 2004, Thyroid : official journal of the American Thyroid Association, 14, 830, 10.1089/1050725042451248 · DOI
- 1980, New England Journal of Medicine, 7, 302
- Kung, 1994, Journal of Clinical Endocrinology & Metabolism, 79, 542, 10.1210/jc.79.2.542 · DOI
- 1998, New England Journal of Medicine, 8, 73
- 1979, JAMA, 30, 2408
- 2005, New England Journal of Medicine, 3, 905
Cited by
Sorted by citations
Items 101–200 of 430
Fetal and Neonatal Thyroid Dysfunction
Léger, J., Delcour, C., & Carel, J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab747 · Cited by 39
Fetal and neonatal thyrotoxicosis
Batra, C. M. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.119505 · Cited by 39
Pedro, A. B., Romaldini, J. H., & Takei, K. (2010) · NeuroImmunoModulation · doi:10.1159/000311519 · Cited by 39
Usefulness of TSH receptor antibodies as biomarkers for Graves’ ophthalmopathy: a systematic review
Seo, S., & Robledo, M. S. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0945-6 · Cited by 38
Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients
Jang, S. Y., Lee, S. Y., Lee, E. J., & Yoon, J. S. (2012) · Eye · doi:10.1038/eye.2012.132 · Cited by 39
Treating the thyroid in the presence of Graves’ ophthalmopathy
Hegedűs, L. D., Bonnema, S. J., Smith, T. J., & Brix, T. H. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.005 · Cited by 37
The Role of Thyrotropin Receptor Activation in Adipogenesis and Modulation of Fat Phenotype
Draman, M. S., Stechman, M., Scott-Coombes, D. M., Dayan, C. M., Rees, D. A., Ludgate, M. E., & Zhang, L. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00083 · Cited by 37
Treatment of adult Graves’ disease
Corvilain, B., Hamy, A., Brunaud, L., Borson‐Chazot, F., Orgiazzi, J., Hachmi, L. B. S., Semrouni, M., Rodien, P., & Lussey‐Lepoutre, C. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.08.003 · Cited by 36
Asymmetric Graves’ Orbitopathy
Panagiotou, G., & Perros, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.611845 · Cited by 36
Fetal neonatal hyperthyroidism: diagnostic and therapeutic approachment
Kurtoğlu, S., & Özdemi̇r, A. (2017) · Türk Pediatri Arşivi · doi:10.5152/turkpediatriars.2017.2513 · Cited by 35
Pedersen, I. B., Handberg, A., Knudsen, N. J., Heickendorff, L., & Laurberg, P. (2010) · Thyroid · doi:10.1089/thy.2009.0105 · Cited by 34
Self-citationTHERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves’ orbitopathy
Campi, I., Vannucchi, G. M., & Salvi, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1164 · Cited by 34
Mestman, J. H. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328357f3d5 · Cited by 35
Park, S. Y., Kim, B. H., Kim, M., Hong, A. R., Park, J. T., Park, H., Choi, M. S., Kim, T. H., Kim, S. W., Kang, H., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02725-x · Cited by 34
Labadzhyan, A., Brent, G. A., Hershman, J. M., & Leung, A. M. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.07.008 · Cited by 33
The effect of radioiodine treatment on the diseased thyroid gland
Riley, A., McKenzie, G. A. G., Green, V., Schettino, G., England, R. J., & Greenman, J. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1665206 · Cited by 34
Davies, T. F., Laurberg, P., & Bahn, R. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00012-5 · Cited by 32
Self-citationGraves Orbitopathy: Update on Diagnosis and Therapy
Melcescu, E., Horton, W. B., Kim, D., Vijayakumar, V., Corbett, J. J., Crowder, K. W., Pitman, K. T., Uwaifo, G. I., & Koch, C. A. (2014) · Southern Medical Journal · doi:10.1097/smj.0000000000000038 · Cited by 32
Kautbally, S., Alexopoulou, O., Daumerie, C., Jamar, F., Mourad, M., & Maiter, D. M. (2012) · European Thyroid Journal · doi:10.1159/000339473 · Cited by 31
Barbesino, G., Goldfarb, M. R., Parangi, S., Yang, J., Ross, D. S., & Daniels, G. H. (2011) · Thyroid · doi:10.1089/thy.2011.0198 · Cited by 31
Struja, T., Jutzi, R., Imahorn, N., Kaeslin, M., Boesiger, F., Kutz, A., Mundwiler, E., Huber, A., KRAENZLIN, M. E., Müeller, B., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0363-6 · Cited by 31
Early Severe Fetal Graves Disease in a Mother After Thyroid Ablation and Thyroidectomy
Donnelly, M. A., Wood, C., Casey, B., Hobbins, J., & Barbour, L. A. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000582 · Cited by 30
Yoshihara, A., Iwaku, K., Noh, J. Y., Watanabe, N., Kunii, Y., Ohye, H., Suzuki, M., Matsumoto, M., Suzuki, N., Tadokoro, R., et al. (2018) · Thyroid · doi:10.1089/thy.2018.0165 · Cited by 30
Evaluating thyroid function in pregnant women
Geno, K. A., & Nerenz, R. D. (2022) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2022.2050182 · Cited by 31
Long-Term Continuous Methimazole or Radioiodine Treatment for Hyperthyroidism
Azizi, F., Yousefi, V., Bahrainian, A., Sheikholeslam, F., Tohidi, M., & Mehrabi, Y. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part2.p17.p1-682 · Cited by 30
The relationship between circulating estradiol and thyroid autoimmunity in males
Chailurkit, L., Aekplakorn, W., & Ongphiphadhanakul, B. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0455 · Cited by 30
zu Hörste, M. M., Pateronis, K., Walz, M. K., Alesina, P. F., Mann, K., Schott, M., Esser, J., & Eckstein, A. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-108855 · Cited by 30
Metamorphic Thyroid Autoimmunity
Ludgate, M. E., & Emerson, C. H. (2008) · Thyroid · doi:10.1089/thy.2008.1551 · Cited by 30
Medical and surgical treatment of thyroid eye disease
Hall, A., & Topliss, D. J. (2020) · Internal Medicine Journal · doi:10.1111/imj.15067 · Cited by 35
Antithyroid Drug Treatment in Graves’ Disease
Chung, J. H. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1070 · Cited by 29
Azizi, F., Abdi, H., Mehran, L., & Amouzegar, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01730-1 · Cited by 29
Laurberg, P., Nygaard, B., Andersen, S., Carlé, A., Karmisholt, J., Krejbjerg, A., Pedersen, I. B., & Andersen, S. L. (2014) · Journal of Thyroid Research · doi:10.1155/2014/165487 · Cited by 29
Self-citationAlternating hyperthyroidism and hypothyroidism in Graves’ disease
Wong, M., & Inder, W. J. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1700 · Cited by 30
Radioiodine therapy and Graves’ disease – Myths and reality
Płazińska, M. T., Sawicka‐Gutaj, N., Czarnywojtek, A., Woliński, K., Kobylecka, M., Karlińska, M., Prasek, K., Zgorzalewicz-Stachowiak, M., Borowska, M., Gut, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226495 · Cited by 28
Stöhr, M., Oeverhaus, M., Lytton, S. D., Horstmann, M., Zwanziger, D., Möller, L. C., Stark, A., Führer‐Sakel, D., Bechrakis, N. E., Berchner‐Pfannschmidt, U., et al. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1373-5523 · Cited by 28
Recent developments in hyperthyroidism
Kharlip, J., & Cooper, D. S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61047-3 · Cited by 27
Thyroid Disorders in Pregnancy
Krajewski, D. A., & Burman, K. D. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.08.004 · Cited by 27
Does thyroid surgery for Graves’ disease improve health-related quality of life?
Scerrino, G., Morfino, G., Paladino, N. C., Paola, V. D., Amodio, E., Gulotta, G., & Bonventre, S. (2012) · Surgery Today · doi:10.1007/s00595-012-0442-z · Cited by 27
Philipp, S., Eckstein, A. K., Stöhr, M., Oeverhaus, M., Lytton, S. D., Horstmann, M., Zwanziger, D., Möller, L. C., Stark, A., Führer‐Sakel, D., et al. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1525-2070 · Cited by 27
Management of Thyroid Disorders in Pregnancy
Chan, S., Marsh, M. S., Gilbert, J., Boelaert, K., Evans, C., & Dhillon‐Smith, R. K. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18088 · Cited by 31
Advances in the pharmacological treatment of Graves’ orbitopathy
Ruchała, M., & Sawicka‐Gutaj, N. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1165606 · Cited by 26
Management of Thyrotoxicosis: Preconception, Pregnancy, and the Postpartum Period
Pearce, E. N. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0356 · Cited by 26
Kim, J., Choi, M. S., Park, J. T., Park, H., Jang, H. W., Choe, J., Kim, J., Kim, J. S., Cho, Y. S., Choi, J. Y., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0756 · Cited by 26
Tanda, M. L., Lai, A., & Bartalena, L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03417.x · Cited by 25
Thyroid cancer in G raves’ disease: is surgery the best treatment for G raves’ disease?
Tamatea, J. A. U., Tu'akoi, K., Conaglen, J. V., Elston, M. S., & Meyer-Rochow, G. Y. (2012) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2012.06233.x · Cited by 25
Radioiodine Therapy for Hyperthyroidism
Villagelin, D., Santos, R. B., & Romaldini, J. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1103014 · Cited by 25
Radioactive Iodine: A Living History
Daniels, G. H., & Ross, D. S. (2023) · Thyroid · doi:10.1089/thy.2022.0344 · Cited by 25
Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease
Azizi, F., Mehran, L., Abdi, H., & Amouzegar, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae456 · Cited by 24
Park, S., Song, E., Oh, H., Kim, M., Jeon, M. J., Kim, W. G., Kim, T. Y., Shong, Y. K., Kim, D. M., & Kim, W. B. (2019) · Endocrine · doi:10.1007/s12020-019-01987-w · Cited by 24
Long-Term Treatment with Antithyroid Drugs: Efficacy and Safety
Malboosbaf, R., & Azizi, F. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.101487 · Cited by 24
Eckstein, A. K., Mann, K., Kahaly, G. J., Grußendorf, M., Reiners, C., Feldkamp, J., Quadbeck, B., Bockisch, A., & Schott, M. (2009) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-009-1072-0 · Cited by 24
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Nwatsock, J. F., Taïeb, D., Tessonnier, L., Mancini, J., Zok, F. D. À., & MUNDLER, O. (2012) · World Journal of Nuclear Medicine · doi:10.4103/1450-1147.98731 · Cited by 22
Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease
Bartalena, L., & Smith, T. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf009 · Cited by 23
The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
Fang, Y., Du, W., Zhang, C.-X., Zhao, S., Song, H., Gao, G.-Q., & Dong, M. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00905-4 · Cited by 21
Performance of a third‐generation TSH‐receptor antibody in a UK clinic
Theodoraki, A., Jones, G., Parker, J. C., Woolman, E., Martin, N. G., Perera, S., Thomas, M., Bunn, C. F., Khoo, B. C. E., Bouloux, P. M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04022.x · Cited by 21
Graves’ hyperthyroidism in pregnancy
Nguyen, C. T., & Mestman, J. H. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000492 · Cited by 22
The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence
Yin, N., Sherman, S. I., Pak, Y., Litofsky, D. R., Gianoukakis, A. G., for the National Thyroid Cancer Treatment Cooperative Study Group, Ain, K. B., Bigos, S. T., Brierley, J. D., Cooper, D. S., et al. (2020) · Thyroid · doi:10.1089/thy.2019.0791 · Cited by 21
Chen, D. Y., Schneider, P. F., Zhang, X. S., He, Z. M., Jin, J., & Chen, T. H. (2011) · Thyroid · doi:10.1089/thy.2010.0348 · Cited by 21
Hyperthyroidism in adolescents
Niedziela, M. (2021) · Endocrine Connections · doi:10.1530/ec-21-0191 · Cited by 20
Pre-Conception Counselling in Graves’ Disease
Lazarus, J. H. (2012) · European Thyroid Journal · doi:10.1159/000336102 · Cited by 20
Muldoon, B., Mai, V. Q., & Burch, H. B. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.02.001 · Cited by 21
Seigel, S. C., & Hodak, S. P. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.016 · Cited by 20
Ko, J., Kook, K. H., Yoon, J. S., Woo, K. I., & Yang, J. W. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-050337 · Cited by 19
Nalla, P., Young, S., Sanders, J. F., Carter, J., Adlan, M. A., Kabelis, K., Chen, S., Furmaniak, J., Smith, B. R., & Premawardhana, L. D. K. E. (2018) · Clinical Endocrinology · doi:10.1111/cen.13908 · Cited by 19
Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves’ disease
Li, X., Wang, G., Lu, Z., Chen, M., Tan, J., & Fang, X. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0252-4 · Cited by 19
Štefanić, M., & Karner, I. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0026-9 · Cited by 18
Controversies in the pharmacological treatment of Graves’ disease in children
Luca, F. D., & Valenzise, M. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1546576 · Cited by 18
Dynamic Changes of TRAb and TPOAb after Radioiodine Therapy in Graves’ Disease
Dong, Q. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.72 · Cited by 18
Ercolano, M. A., Drnovsek, M. L., Croome, M. C. S., Moos, M., Fuentes, A. M., Viale, F., Feldt-Rasmussen, U., & Gauna, A. T. (2013) · Thyroid Research · doi:10.1186/1756-6614-6-11 · Cited by 17
Khamisi, S., Lundqvist, M., Engström, B. E., Larsson, A., Karlsson, F. A., & Ljunggren, Ö. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2021-0596 · Cited by 17
Hyperthyroidism, Exophthalmos, and Goiter: Historical Notes on the Orbitopathy
Lindholm, J., & Laurberg, P. (2010) · Thyroid · doi:10.1089/thy.2009.0340 · Cited by 17
Self-citationAllam, M. M., El‐Zawawy, H. T., Okda, A. A. K., Alshaikh, A. A., & Ghazy, R. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168936 · Cited by 16
Treatment options for Graves' orbitopathy
Marcocci, C., Altea, M. A., & Leo, M. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.668529 · Cited by 16
The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves’ Disease
Lindgren, O., Asp, P., Sundlöv, A., Tennvall, J., Shahida, B., Planck, T., Åsman, P., & Lantz, M. (2019) · European Thyroid Journal · doi:10.1159/000495504 · Cited by 18
Success rate of radioactive iodine treatment for children and adolescent with hyperthyroidism
Namwongprom, S., Dejkhamron, P., & Unachak, K. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01339-w · Cited by 16
Benlarbi, H., Simon, D., Rosenblatt, J., Dumaine, C., de Roux, N., Chevenne, D., Storey, C., Poidvin, A., Martinerie, L., Carel, J., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1320 · Cited by 16
Long-term antithyroid drug therapy
Cooper, D. S. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000656 · Cited by 16
Chiappori, A., Villalta, D., Bossert, I., Ceresola, E., Lanaro, D., Schiavo, M., Bagnasco, M., & Pesce, G. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346581 · Cited by 16
High levels of circulating triiodothyronine induce plasma cell differentiation
Bloise, F. F., de Oliveira, F. L., Nóbrega, A., Vasconcellos, R., Cordeiro, A., de Paiva, L. S., Taub, D. D., Borojević, R., Pazos-Moura, C. C., & Coelho, V. D. M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0315 · Cited by 16
Xie, P., Shen, L., Peng, R., Wang, Y., Yin, Q., Chen, X., Zhou, J., Ning, G., Wang, W., Wang, S., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae472 · Cited by 15
Doroudian, S., Pedersen, I. B., Knudsen, C. S., Handberg, A., & Andersen, S. L. (2017) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2017.1354257 · Cited by 15
Albakri, A. (2018) · Integrative Molecular Medicine · doi:10.15761/imm.1000350 · Cited by 16
Management of hyperthyroidism during pregnancy in Asia
Azizi, F., Amouzegar, A., Mehran, L., Alamdari, S., Subekti, I., Vaidya, B., Poppe, K. G., Sarvghadi, F., Luis, T. S., & Akamizu, T. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0145 · Cited by 15
Gietka‐Czernel, M., Dębska, M., Kretowicz, P., Zgliczyński, W., & Ołtarzewski, M. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0035 · Cited by 15
Management Aspects of Medical Therapy in Graves Disease
Shah, R., Adamson, S. E., & Jasim, S. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.12.012 · Cited by 14
Clinical Features of Chinese Patients with Thyroid Eye Disease: A Multicenter Retrospective Study
Lei, C., Lyu, X., Ren, Y., Wei, D., Zhang, S., Zhang, Y., Wang, L., Liu, L., Wen, J., Liu, X., et al. (2025) · Thyroid · doi:10.1177/10507256251359559 · Cited by 18
Case report: clues to the diagnosis of an unsuspected massive levothyroxine overdose
Allen, K. M., Crawford, V., Conaglen, J. V., & Elston, M. S. (2015) · Canadian Journal of Emergency Medicine · doi:10.1017/cem.2014.75 · Cited by 14
Graves' Disease that Developed Shortly after Surgery for Thyroid Cancer
Yu, H. M., Park, S. H., Lee, J. M., & Park, K. S. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.3.226 · Cited by 14
Important considerations in the management of Graves’ disease in pregnant women
Okosieme, O. E., & Lazarus, J. H. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1054375 · Cited by 14
Cosentino, G., Lanzolla, G., Comi, S., Maglionico, M. N., Posarelli, C., Ciampa, D. A., Menconi, F., Rocchi, R., Latrofa, F., Figus, M., et al. (2025) · Thyroid · doi:10.1089/thy.2024.0633 · Cited by 14
Negro, R., Beck‐Peccoz, P., Chiovato, L., Garofalo, P., Guglielmi, R., Papini, E., Tonacchera, M., Vermiglio, F., Vitti, P., Zini, M., et al. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347071 · Cited by 13
McLachlan, S. M., Aliesky, H. A., Chen, C., & Rapoport, B. (2012) · Thyroid · doi:10.1089/thy.2012-0008 · Cited by 13
Erdoğan, M. F., Demir, Ö., Ersoy, R., Gül, K., Aydoğan, B. İ., Üç, Z. A., Mete, T., Ertek, S., Ünlütürk, U., Çakır, B., et al. (2016) · European Thyroid Journal · doi:10.1159/000444796 · Cited by 13
Caron, P. J. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.01.006 · Cited by 13
Harsini, S., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00001-3 · Cited by 13
EUGOGO, Lazarus, J. H., Bartalena, L., Marcocci, C., Kahaly, G. J., Krassas, G. E., & Wiersinga, W. M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346613 · Cited by 13
Utility of Antibodies in the Diagnoses of Thyroid Diseases: A Review Article
Gupta, A. K., & Kumar, S. (2022) · Cureus · doi:10.7759/cureus.31233 · Cited by 12
Bluszcz, G., Bednarczuk, T., Bartoszewicz, Z., Kondracka, A., Walczak, K., Żurecka, Z., Demkow, U. A., & Miśkiewicz, P. (2018) · Central European Journal of Immunology · doi:10.5114/ceji.2018.80224 · Cited by 12
Galofré, J. C., Duntas, L. H., Premawardhana, L. D. K. E., & Davies, T. F. (2012) · Journal of Thyroid Research · doi:10.1155/2012/809231 · Cited by 12
Kawabata, M., Inoue, N., Watanabe, M., Kobayashi, A., Hidaka, Y., Miyauchi, A., & Iwatani, Y. (2021) · Autoimmunity · doi:10.1080/08916934.2021.1946796 · Cited by 11
Metadata
- Authors
- Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O.
- Affiliations
- Aalborg University Hospital (DK)
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Corresponding author
- Laurberg, Peter
- ORCID
- Wallin, Göran
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01
- Volume
- 158
- Issue
- 1
- Pages
- 69-75
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2161176285
- Cited by
- 428
- References
- 36
- Citations by year
- 2026: 7 · 2025: 32 · 2024: 22 · 2023: 19 · 2022: 30 · 2021: 31 · 2020: 30 · 2019: 28 · 2018: 30 · 2017: 19 · 2016: 19 · 2015: 29 · 2014: 28 · 2013: 21 · 2012: 27
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- Graves' disease, TSH receptor antibodies, antithyroid drugs, thyroid surgery, radioiodine therapy, hyperthyroidism treatment, levothyroxine
- MeSH terms
- Adult, Autoantibodies, Graves Disease, Humans, Iodine Radioisotopes, Middle Aged, Prospective Studies, Receptors, Thyrotropin, Antithyroid Agents, Thyroidectomy, Thyroxine, Time Factors, Triiodothyronine, Autoimmunity, Treatment Outcome, Immunoglobulins, Thyroid-Stimulating
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
